Preferences and Willingness to Pay for Health States Prevented by Pneumococcal Conjugate Vaccine

Pediatrics

Volumn 113, Issue 2, 2004, Pages 283-290

  Prosser, Lisa A ^a,b   Ray, G Thomas ^c   O'Brien, Megan ^a   Kleinman, Ken ^a   Santoli, Jeanne ^d   Lieu, Tracy A ^a,b,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD PILGRIM HEALTH CARE   (United States)

^c DIVISION OF RESEARCH   (United States)

^d CENTERS FOR DIS CONTR AND PREV   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Pneumococcal conjugate vaccine; Preferences; Utilities; Willingness to pay

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADULT; ARTICLE; ATTITUDE; BACTERIAL MENINGITIS; CHILD PARENT RELATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OTITIS MEDIA; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; VACCINATION;

ADULT; BACTEREMIA; CHILD, PRESCHOOL; DATA COLLECTION; HUMANS; INFANT; MENINGITIS, PNEUMOCOCCAL; MODELS, ECONOMIC; OTITIS MEDIA; PARENTS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; QUALITY-ADJUSTED LIFE YEARS; RISK; TIME; UNITED STATES;

EID: 0842324922     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.113.2.283     Document Type: Article

References (28)

1. Lieu TA, Ray GT. Summary of updates and revisions to: "Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children" (Lieu TA, Ray GT, Black SB, et al. JAMA 2000;283:1460-1468). Presentation to CDC Advisory Review Panel, Atlanta, GA, May 29, 2000. See also www.dacp.org/pneumopaper.html
2. Lieu TA, Ray GT. Summary of updates and revisions to: "Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children" (Lieu TA, Ray GT, Black SB, et al. JAMA 2000;283:1460-1468). Presentation to CDC Advisory Review Panel, Atlanta, GA, May 29, 2000. See also www.dacp.org/pneumopaper.html
3. Bisonni RS, Lawler FH, Pierce L. Recurrent otitis media: a cost-utility analysis of simulated treatments using tympanostomy tubes vs. antibiotic prophylaxis. Fam Pract Res J. 1991;11:371-378
4. Oh PI, Maerov P, Pritchard D, Knowles SR, Einarson TR, Shear NH. A cost-utility analysis of second-line antibiotics in the treatment of acute otitis media in children. Clin Ther. 1996;18:160-181
5. Bergus GR, Lofgren MM. Tubes, antibiotic prophylaxis, or watchful waiting: a decision analysis for managing recurrent acute otitis media. J Fam Pract. 1998;46:304-310
6. Sorum PC. Measuring patient preferences by willingness to pay to avoid: the case of acute otitis media. Med Decis Making. 1999;19:27-37
7. Gold MR, Siegel JE, Russell, et al. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996
8. Corso P, Hammitt JK, Graham JD. Valuing mortality-risk reduction: using visual aids to improve the validity of contingent valuation. J Risk Uncertain. 2001;23:165-184
9. Sheskin DJ. Handbook of Parametric and Nonparametric Statistical Procedures. 2nd ed. New York, NY: Chapman and Hall; 2000:319-329
10. Breslow NE, Clayton DG. Approximate inference in generalized linear mixed models. J Am Stat Assoc. 1993;88:25
11. 1998 USA Statistics in Brief-Law, Education, Communications, Transportation, Housing. Available at: www.census.gov/statab/www/part2. Accessed February 8, 2000
12. USA Statistics in Brief. Available at: www.census.gov/statab/www/part1-part4. Accessed April 2, 2000
13. Salkeld G, Cameron ID, Cumming RG, et al. Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BMJ. 2000;320:341-346
14. Brown GC, Sharma S, Brown MM, et al. Utility values and age-related macular degeneration. Arch Ophthalmol. 2000;118:47-51
15. Doubilet P, Weinstein MC, McNeil BJ. Use and misuse of the term "cost-effective" in medicine. N Engl J Med. 1986;314:253-256
16. Stone PW, Teutsch S, Chapman RH, Bell C, Goldie SJ, Neumann PH. Cost-utility analyses of clinical preventive services. Published ratios, 1976-1997. Am J Prev Med. 2000;19:15-23
17. Liu J-T, Hammitt JK, Wange J-D, Liu J-L. Mother's willingness to pay for her own and her child's health: a contingent valuation study in Taiwan. Health Econ. 2000;9:319-326
18. Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index system for assessing health-related quality of life in clinical studies. Ann Med. 2001;33:375-384
19. Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population survey. Health Econ. 1996;5:141-154
20. Bennett JE, Sumner W II, Downs SM, Jaffe DM. Parents' utilities for outcomes of occult bacteremia. Arch Pediatr Adolesc Med. 2000;154:43-48
21. Johannesson M, Weinstein MC. Designing and conducting cost-benefit analyses. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1996:1085-1092
22. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. New York, NY: Oxford University Press; 1999:219-221
23. Juniper EF, Guyatt GH, Feeny DH, Griffith LE, Ferrie PJ. Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties. Eur Respir J. 1997;10:2285-2294
24. Neumann PJ, Kuntz KM, Leon J, et al. Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers. Med Care. 1999;37:27-32
25. Saigal S, Rosenbaum P, Hoult L, et al. Conceptual and methodological issues in assessing health-related quality of life in children and adolescents: illustration from studies of extremely low birthweight survivors. In: Drotar D, ed. Measuring Health-Related Quality of Life in Children and Adolescents: Implications for Research and Practice. Mahwah, NJ: Lawrence Erlbaum Associates; 1998:151-169
26. Saigal S, Stoskopf BL, Feeny D, et al. Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents. JAMA. 1999;281:1991-1997
27. Kramer MS, Etezadi-Amoli J, Ciampi A, et al. Parents' versus physicians' values for clinical outcomes in young febrile children. Pediatrics. 1994;93:697-702
28. Kramer MS, MacLellan A, Ciampi A, Etezadi-Amoli J, Leduc DG. Parents' versus physicians' utilities (values) for clinical outcomes in potentially bacteremic children. J Clin Epidemiol. 1990;43:1319-1325